Greenberg Traurig’s Karen Corallo to Speak at FDLI’s Introduction to U.S. Drug Law and Regulation Course

Share Article

Global law firm Greenberg Traurig, LLP Of Counsel Karen C. Corallo will be speaking at the Food and Drug Law Institute (FDLI) Introduction to U.S. Drug Law and Regulation course, July 24-25, in South San Francisco, California.

Global law firm Greenberg Traurig, LLP Of Counsel Karen C. Corallo will be speaking at the Food and Drug Law Institute (FDLI) Introduction to U.S. Drug Law and Regulation course, July 24-25, in South San Francisco, California. Attendees will explore the essentials of drug law and regulation and gain a comprehensive understanding of the various administrative agencies that impact the industry.

Corallo will speak at the session titled, “Overview of Drug Law and Regulation,” July 24 from 8:35 a.m. – 10:00 a.m. PT. Specifically, Corallo will address landmark legislative enactments for drug regulation and development of today’s statutory framework. She will provide historical context and discuss major statutory underpinnings.

Corallo is the former Director of the U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Division of Drug Imports, Exports, Recalls, and Shortages. In that role, she authored and executed the FDA’s global drug imports strategy, managed operations and supervised staff, and spearheaded important drug policy initiatives. Before that, Karen was Associate Chief Counsel in FDA’s Office of Chief Counsel, where she worked with the Department of Justice Consumer Protection Branch on civil enforcement matters involving all FDA-regulated commodities and with U.S. Attorneys’ Offices across the country on criminal enforcement matters. In addition to her government work, Corallo was a commercial litigation partner for a global law firm and also served as in-house counsel at a Fortune 100 company.

In addition, Corallo represents pharmaceutical, medical device, and food industry clients and advises them on administrative, regulatory, and enforcement matters.

About Greenberg Traurig’s Health Care & FDA Practice: Greenberg Traurig’s multidisciplinary Health Care & FDA Practice provides strategic counsel to a diverse group of companies and other organizations, helping them to respond proactively to the rapidly changing healthcare marketplace. The group combines dedicated experience in health care regulatory compliance and operational matters with the firm’s capabilities in corporate & securities, finance, tax, antitrust, ERISA, commercial and governmental litigation, restructuring, intellectual property and biotechnology, in order to provide a wide range of legal services. For more information, click here.

About Greenberg Traurig, LLP: Greenberg Traurig, LLP (GT) has more than 2,000 attorneys in 38 offices in the United States, Latin America, Europe, Asia and the Middle East. GT has been recognized for its philanthropic giving, was named the largest firm in the U.S. by Law360 in 2017, and is among the Top 20 on the 2017 Am Law Global 100. Web: http://www.gtlaw.com Twitter: @GT_Law.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Lourdes Brezo Martinez
@GT_Law
Follow >
Visit website